1. "2018"
Formats
  1. Journal Article (3011)
  2. Meeting Abstract (1948)
  3. Book Section (206)
  4. Conference Paper (38)
  5. Book Whole (11)
  6. Editorial (4)
  7. Review (4)
  8. Miscellaneous (2)
  9. Correspondence (1)
Groups
  1. Department of Medicine (2296)
  2. Solid Tumor Oncology Division (1378)
  3. GSK Faculty (1136)
  4. Sloan Kettering Institute Postdocs (1044)
  5. Surgery (870)
  6. Center for Hematologic Malignancies (863)

More Groups

People
  1. Sergio Giralt (87)
  2. Matthew Hellmann (78)
  3. Jedd Wolchok (74)
  4. Marc Ladanyi (74)
  5. Robert Motzer (71)
  6. Nancy Lee (64)

More People

Years
  1. 2018 (5225)
Publications
  1. Journal of Clinical Oncology (562)
  2. Blood (249)
  3. Cancer Research (183)
  4. Annals of Oncology (140)
  5. International Journal of Radiation Oncology, Biology, Physics (137)
  6. Modern Pathology (127)

More Publications

Publishers
  1. Elsevier Inc. (691)
  2. American Society of Clinical Oncology (605)
  3. Springer (410)
  4. American Association for Cancer Research (299)
  5. Oxford University Press (291)
  6. American Society of Hematology (273)

More Publishers

Results (5225)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1 study using mogamulizumab (KW-0761) to deplete regulatory T cells in combination with checkpoint inhibitors durvalumab (MEDI4736) or tremelimumab in subjects with advanced solid tumors
    Meeting Abstract

    Zamarin, D.; Hamid, O.; Nayak, A.; Sahebjam, S.; Sznol, M.; Collaku, A.; Fox, F.; Marshall, M.; Hong, D.
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Preliminary clinical data from a pilot study of NY-ESO-1c259T-cells in advanced myxoid/round cell liposarcoma
    Meeting Abstract

    D'Angelo, S.; Stadanlick, J.; Druta, M.; Liebner, D.; Schuetze, S.; Van Tine, B.; Tap, W.; Britten, C.; Chagin, K.; Hasan, A.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • The personal vaccine, NEO-PV-01 with anti-PD1, induces neoantigenspecific de novo tumor-related immunity in patients with advanced cancer
    Meeting Abstract

    Hu-Lieskovan, S.; Govindan, R.; Naing, A.; Friedlander, T.; Margolin, K.; Lin, J.; Bhardwaj, N.; Hellmann, M.; Srinivasan, L.; Greshock, J.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Comparison of biomarker assay modalities in anti-PD-(L)1 monotherapy: A meta-analysis
    Meeting Abstract

    Lu, S.; Lu, S.; Danilova, L.; Rimm, D.; Hoyt, C.; Hellmann, M.; Taube, J.
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Frameshift indel selectively correlates with immunotherapy outcome for advanced NSCLC
    Meeting Abstract

    Park, W.; Park, L. C.; Florou, V.; Saravia, D.; Chang, S.; Wang, S.; Chiec, L.; Rahbari, A.; Viveiros, P.; Sukhadia, B.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Commensal bacteria Bifidobacterium stimulates an anti-tumor response via cross-reactivity
    Meeting Abstract

    Bessell, C.; Bessell, C.; Isser, A.; Havel, J.; Lee, S.; Zhou, R.; Schneck, J.; Bell, D.
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects
    Meeting Abstract

    Hirschhorn-Cymerman, D.; Ricca, J.; Gasmi, B.; De Henau, O.; Mangarin, L.; Budhu, S.; Li, Y.; Cortez, C.; Liu, C.; Zappasodi, R.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • TCR repertoire correlates of response in tumor-bearing mice treated with radiotherapy and CTLA-4 blockadeRudqvis
    Meeting Abstract

    Rudqvist, N. P.; Lhuillier, C.; Wennerberg, E.; Sims, J.; Demaria, S.
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Targeting phosphatidylserine enhances the anti-tumor response to radiation therapy and immune checkpoint blockade in a preclinical melanoma model
    Meeting Abstract

    Budhu, S.; Giese, R.; Gupta, A.; Schad, S.; De Henau, O.; Zappasodi, R.; Campesato, L.; Barker, C.; Wolchok, J.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Developing a cross-reactive heteroclitic peptide cancer vaccine targetting poorly immunogenic mutant calreticulin in myeloproliferative neoplasms
    Meeting Abstract

    Gigoux, M.; Elf, S.; Ciboddo, M.; Zappasodi, R.; Pourpe, S.; Abdelfattah, N.; Chan, T.; Abdel-Wahab, O.; Mullally, A.; Merghoub, T.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save